These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1907709)

  • 41. Data acquisition and analysis using conventional multimedia computer: a cost effect method for computerising electrophysiological data.
    Sankar V; Namasivayam A; Muthusamy R
    Indian J Physiol Pharmacol; 1999 Jul; 43(3):403-4. PubMed ID: 10776494
    [No Abstract]   [Full Text] [Related]  

  • 42. Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.
    Obenchain RL; Robinson RL; Swindle RW
    J Biopharm Stat; 2005; 15(3):419-36. PubMed ID: 15920889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Breast cancer screening lacks effectiveness].
    Merkelbach JW
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):139-40. PubMed ID: 11826675
    [No Abstract]   [Full Text] [Related]  

  • 44. How much quality control is enough? A cost-effectiveness model for clinical laboratory quality control procedures (illustrated by its application to a ligand-assay-based screening program).
    Rodgers RP
    Med Decis Making; 1987; 7(3):156-67. PubMed ID: 3112504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjusting for bias in C/E ratio estimates.
    Stinnett AA
    Health Econ; 1996; 5(5):470-2. PubMed ID: 8922973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
    O'Hagan A; Stevens JW
    Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial.
    Purmonen TT; Pänkäläinen E; Turunen JH; Asseburg C; Martikainen JA
    Acta Oncol; 2011 Apr; 50(3):344-52. PubMed ID: 21299447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness analysis methods for the REACT Study.
    Duren-Winfield V; Berry MJ; Jones SA; Clark DH; Sevick MA
    West J Nurs Res; 2000 Jun; 22(4):460-74. PubMed ID: 10826254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comments on the "classical equations" given in J. Chromatogr A 1024 (2004) 195-207.
    Ettre LS
    J Chromatogr A; 2005 May; 1076(1-2):220-1; discussion 222-3. PubMed ID: 15974094
    [No Abstract]   [Full Text] [Related]  

  • 50. Data transformations.
    Healy MJ
    Arch Dis Child; 1993 Aug; 69(2):260-4. PubMed ID: 8215535
    [No Abstract]   [Full Text] [Related]  

  • 51. More than stats to dice throwing.
    Stewart I
    Nature; 2019 Jul; 571(7764):174. PubMed ID: 31289397
    [No Abstract]   [Full Text] [Related]  

  • 52. Mathematics. A correlation for the 21st century.
    Speed T
    Science; 2011 Dec; 334(6062):1502-3. PubMed ID: 22174235
    [No Abstract]   [Full Text] [Related]  

  • 53. Statistical analysis of cost effectiveness data.
    O'Brien B
    J Rheumatol; 1999 Oct; 26(10):2078-80. PubMed ID: 10529119
    [No Abstract]   [Full Text] [Related]  

  • 54. Statistical issues in cost-effectiveness analyses.
    Thompson S
    Stat Methods Med Res; 2002 Dec; 11(6):453-4. PubMed ID: 12516983
    [No Abstract]   [Full Text] [Related]  

  • 55. Cost-effectiveness concepts and the CE plane.
    Ganiats TG
    Med Decis Making; 1991; 11(2):147. PubMed ID: 1907709
    [No Abstract]   [Full Text] [Related]  

  • 56. The CE plane: a graphic representation of cost-effectiveness.
    Black WC
    Med Decis Making; 1990; 10(3):212-4. PubMed ID: 2115096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Roaming through methodology. XIX. Cost-effectiveness ratios].
    Rutten FF
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1311-4. PubMed ID: 10918910
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.